Skip to main content

Table 1 Demographic and clinical data for OCD patients and healthy controls

From: Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder

Variables

Pre-treatment groups (case)

 

Treatment remission groups (case)

 
 

OCD group (19)

Controls (30)

P

SSRI (11)

SSRI/quetiapine (8)

P

sex (female, %)

9(47)

13(43)

0.214

5(45)

4(50)

0.305

age (years)

27.21 ± 8.75

29.25 ± 6.81

0.291

28.18 ± 8.2

26.78 ± 7.66

0.286

education (years)

12.66 ± 3.17

13.30 ± 2.47

0.667

12.12 ± 3.77

12.53 ± 3.13

0.797

length of illness (years)

2.47 ± 1.33

 

2.33 ± 1.99

2.97 ± 1.34

0.714

pre-treatment scales

 Y-BOCS total score

24.55 ± 6.72

11.12 ± 5.12

0.013

24.36 ± 6.22

24.55 ± 7.41

0.731

 HAMD total score

21.21 ± 4.36

16.33 ± 2.41

0.044

21.30 ± 4.11

21.00 ± 4.17

0.712

Post-treatment scales

 Y-BOCS total score

12.48 ± 5.20 *

 

11.51 ± 5.01 *

11.36 ± 5.14 *

0.512

 HAMD total score

17.31 ± 3.49 *

 

17.03 ± 3.18 *

17.21 ± 3.33 *

0.647

  1. *p < 0.01, compared to the pre-treatment score.